Actuate Therapeutics Inc
Actuate Therapeutics Inc（ACTU）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · ACTU · 截至 2026年6月9日
活动摘要
买入笔数
6
P-Purchase only
卖出笔数
1
近12个月
买卖比
6.00
Buy/Sell (by trades)
整体情绪
Actuate Therapeutics Inc内部人在过去近12个月净买入股份，可能反映对公司前景的信心。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
ACTU 季度内部人买卖趋势
ACTU 内幕交易卖出 · ACTU 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · ACTU CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
ACTU 高管卖出股份 · ACTU 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Feb 13, 2026 | SCHMITT DANIEL M President, CEO and Director | Option | 272,055 | — | Form 4 |
| Feb 13, 2026 | SCHMITT DANIEL M President, CEO and Director | Other | 121,874 | $528K | Form 4 |
| Jan 5, 2026 | THOMSON TODD S Director | Sale | 280,000 | $1.62M⚡ | Form 4 |
| Jun 27, 2025 | Bios Equity COF, LP Director | Purchase | 71,428 | $500K | Form 4 |
| Jun 27, 2025 | Kreis Leslie W. Director | Purchase | 71,428 | $500K | Form 4 |
| Jun 27, 2025 | Fletcher Aaron G.L. Director | Purchase | 71,428 | $500K | Form 4 |
| May 21, 2014 | PATTERSON ARTHUR C Director | Award | 16,000 | — | Form 4 |
| May 22, 2013 | PATTERSON ARTHUR C Director | Award | 16,000 | — | Form 4 |
| Dec 12, 2012 | PATTERSON ARTHUR C Director | Option | 10,000 | $38K | Form 4 |
| Dec 12, 2012 | PATTERSON ARTHUR C Director | Option | 10,000 | $20K | Form 4 |
| Dec 12, 2012 | PATTERSON ARTHUR C Director | Option | 10,000 | $37K | Form 4 |
| Dec 12, 2012 | PATTERSON ARTHUR C Director | Option | 10,000 | $19K | Form 4 |
| Dec 12, 2012 | PATTERSON ARTHUR C Director | Option | 16,000 | $67K | Form 4 |
| Dec 12, 2012 | PATTERSON ARTHUR C Director | Option | 25,000 | $115K | Form 4 |
| Dec 12, 2012 | PATTERSON ARTHUR C Director | Option | 25,000 | $116K | Form 4 |
| Dec 12, 2012 | PATTERSON ARTHUR C Director | Option | 30,000 | $121K | Form 4 |
| Dec 12, 2012 | PATTERSON ARTHUR C Director | Option | 90,000 | $134K | Form 4 |
| May 24, 2012 | PATTERSON ARTHUR C Director | Option | 10,000 | $56K | Form 4 |
| May 23, 2012 | PATTERSON ARTHUR C Director | Award | 8,000 | — | Form 4 |
| Oct 12, 2011 | PATTERSON ARTHUR C Director | Option | 15,000 | $56K | Form 4 |
| May 25, 2011 | PATTERSON ARTHUR C Director | Award | 8,000 | — | Form 4 |
| May 26, 2010 | PATTERSON ARTHUR C Director | Award | 8,000 | — | Form 4 |
| Aug 27, 2009 | BEITZEL GEORGE B Director | Option | 10,000 | $19K | Form 4 |
| Aug 27, 2009 | BEITZEL GEORGE B Director | Option | 10,000 | $20K | Form 4 |
| Aug 27, 2009 | BEITZEL GEORGE B Director | Sale | 20,000 | $115K | Form 4 |
SCHMITT DANIEL M
President, CEO and Director
日期
Feb 13
股数
121,874
均价
$4.33
总金额
$528K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 ACTU 内幕交易
ACTU 内幕交易
Actuate Therapeutics Inc（ACTU）内幕交易数据来源于公司内部人（包括SCHMITT DANIEL M (President, CEO and Director), THOMSON TODD S (Director), Bios Equity COF, LP (Director)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。ACTU内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Actuate Therapeutics Inc机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
ACTU 内幕交易 · 5个问题Actuate Therapeutics Inc（ACTU）的内部人包括高管和董事，如SCHMITT DANIEL M (President, CEO and Director), THOMSON TODD S (Director), Bios Equity COF, LP (Director)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026